Selecta Biosciences Announces Pricing of Initial Public Offering
(Thomson Reuters ONE) -
WATERTOWN, Mass., June 21, 2016 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc.
(Nasdaq:SELB) today announced the pricing of its initial public offering of
5,000,000 shares of common stock at a public offering price of $14.00 per share,
before underwriting discounts and commissions. All of the common stock is being
offered by Selecta Biosciences. In addition, the company has granted the
underwriters a 30-day option to purchase up to an additional 750,000 shares of
common stock from the company at the initial public offering price, less the
underwriting discounts and commissions, to cover over-allotments, if any. The
company's common stock is expected to begin trading on the NASDAQ Global Market
on Wednesday, June 22, 2016 under the ticker symbol "SELB."
UBS Investment Bank and Stifel are acting as joint book-running managers for the
offering. Canaccord Genuity and Needham & Company are acting as co-managers for
the offering.
A registration statement relating to the securities being sold in the offering
has been declared effective by the Securities and Exchange Commission. This
offering is being made only by means of a prospectus. Copies of the final
prospectus relating to this offering may be obtained, when available, by
contacting: UBS Securities LLC, Attention: Prospectus Department, 1285 Avenue of
the Americas, New York, NY 10019, or by telephone (888) 827-7275; or Stifel,
Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street,
Suite 3700, San Francisco, CA 94104, or by telephone at (415) 364-2720 or by
email to syndprospectus(at)stifel.com.
This press release shall not constitute an offer to sell or the solicitation of
an offer to buy, nor shall there be any sale of, these securities in any state
or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to the registration or qualification under the securities laws of such
state or jurisdiction.
Contact
Stephanie Ascher
Stern Investor Relations, Inc.
+1-212-362-1200
stephanie(at)sternir.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Selecta Biosciences Inc via GlobeNewswire
[HUG#2022323]
Datum: 22.06.2016 - 02:49 Uhr
Sprache: Deutsch
News-ID 479252
Anzahl Zeichen: 2859
contact information:
Town:
Watertown
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 320 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Selecta Biosciences Announces Pricing of Initial Public Offering"
steht unter der journalistisch-redaktionellen Verantwortung von
Selecta Biosciences Inc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
